Gunnar Hilmar Gislason


    Research activity per year

    Personal profile


    Epidemiology, prevention and treatment of cardiovascular disease, large-scale register-based studies, prediction models, pharmacoepidemiology


    Main research areas

    My main fields of research are large-scale register based studies related to epidemiology and treatment of cardiovascular disease, implementation of evidence-based treatments and cardiovascular complications of cardiovascular and non-cardiovascular treatments. I have extensive experience working with the Danish national registries and linkage of clinical data with administrative databases.


    Current research

    Registerbased studies within oral anticoagulation (vitamin-k antagonists and NOACs), anti-thrombotic treatment, sudden cardiac death and out-of-hospital cardiac arrest, heart failure, atrial fibrillation, ischemic heart disease, drug-drug interactions, drug safety studies, oncocardiology, diabetes and CV risk, the DANNOAC study (non-interventional cluster-randomized trial on NOAC treatment). 

    Potential conflicts of interest

    Research grants from AstraZeneca, Bayer, Pfizer, Bristol Myers Squibb, Boehringer Ingelheim.


    Dive into the research topics where Gunnar Hilmar Gislason is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
    • 1 Similar Profiles

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or